Advanced search
Publication Cover
Expert Review of Vaccines Volume 15, 2016 - Issue 7
Submit an article Journal homepage
1,177
Views
5
CrossRef citations to date
0
Altmetric
Editorial

Design of tuberculosis vaccine trials under financial constraints

Alberto L. García-BasteiroCentro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique;ISGlobal, Barcelona Ctr. Int. Health Res. (CRESIB), Hospital Clínic - Universitat de Barcelona, Barcelona, Spain;Amsterdam Institute for Global Health and Development (AIGHD), Amsterdam, The NetherlandsCorrespondence[email protected]
,
Morten RuhwaldHuman immunology, Dept. of infectious disease immunology, Statens Serum Institut, Copenhagen, Denmark
&
Christoph LangeDivision of Clinical Infectious Diseases, Research Center Borstel, Borstel, Germany;German Center for Infection Research, Clinical Tuberculosis Center, Borstel, Germany;International Health/Infectious Diseases, University of Lübeck, Lübeck, Germany;Department of Medicine, Karolinska Institute, Stockholm, Sweden;Department of Internal Medicine, University of Namibia School of Medicine, Windhoek, Namibia
Pages 799-801 | Received 04 Feb 2016, Accepted 11 Apr 2016, Published online: 09 May 2016

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Stefan H.E. Kaufmann, January Weiner$suffix/text()$suffix/text() & Jeroen Maertzdorf. (2017) Accelerating tuberculosis vaccine trials with diagnostic and prognostic biomarkers. Expert Review of Vaccines 16:8, pages 845-853.
Read now

Articles from other publishers (4)

Alberto L. Garcia-Basteiro, Richard G. White, Dereck Tait, Alexander C. Schmidt, Molebogeng X. Rangaka, Matthew Quaife, Elisa Nemes, Robin Mogg, Philip C. Hill, Rebecca C. Harris, Willem A. Hanekom, Mike Frick, Andrew Fiore-Gartland, Tom Evans, Alemnew F. Dagnew, Gavin Churchyard, Frank Cobelens, Marcel A. Behr & Mark Hatherill. (2022) End-point definition and trial design to advance tuberculosis vaccine development. European Respiratory Review 31:164, pages 220044.
Crossref
Mark Hatherill, Richard G. White & Thomas R. Hawn. (2020) Clinical Development of New TB Vaccines: Recent Advances and Next Steps. Frontiers in Microbiology 10.
Crossref
Christina Jensen, Line Lindebo Holm, Erik Svensson, Claus Aagaard & Morten Ruhwald. (2017) Optimisation of a murine splenocyte mycobacterial growth inhibition assay using virulent Mycobacterium tuberculosis. Scientific Reports 7:1.
Crossref
Morten Ruhwald & Peter L Andersen. (2016) New tests for detection of Mycobacterium tuberculosis infection: sufficient to meet the WHO 2035 targets? . Future Microbiology 11:9, pages 1101-1104.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.